Gabelli Funds’s Aerie Pharmaceuticals AERI Stock Holding History

Gabelli Funds’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-452,567	Closed	-$6.85M	–	1354
2022 Q3	$6.85M	Buy	+452,567	New	+$5.26M	0.06%	379

Gabelli Funds's AERI Position: Q4 2022 in Review

Gabelli Funds sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 452,567 shares — an estimated $6.85M sold.

Gabelli Funds first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $6.85M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Gabelli Funds reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Gabelli Funds sold 452,567 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6.85M.
Gabelli Funds first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Gabelli Funds's Aerie Pharmaceuticals position peaked at $6.85M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.